|
Volumn 35, Issue 3, 2002, Pages 320-326
|
Assessment of mortality in patients enrolled in a risedronate clinical trial program: A retrospective cohort study
a b c d e f g |
Author keywords
Bisphosphonates; Cancer; Mortality; Retrospective cohort study; Risedronate; Stroke
|
Indexed keywords
BISPHOSPHONIC ACID DERIVATIVE;
PLACEBO;
RISEDRONIC ACID;
ADULT;
AGED;
ARTICLE;
CARDIOVASCULAR DISEASE;
CAUSE OF DEATH;
CLINICAL TRIAL;
COHORT ANALYSIS;
CONTROLLED CLINICAL TRIAL;
CONTROLLED STUDY;
DIGESTIVE SYSTEM CANCER;
DRUG EFFICACY;
DRUG SAFETY;
FEMALE;
HUMAN;
LUNG CANCER;
MAJOR CLINICAL STUDY;
MORTALITY;
NORTH AMERICA;
OSTEOPOROSIS;
PHASE 3 CLINICAL TRIAL;
PRIORITY JOURNAL;
RANDOMIZED CONTROLLED TRIAL;
RETROSPECTIVE STUDY;
|
EID: 0036599249
PISSN: 02732300
EISSN: None
Source Type: Journal
DOI: 10.1006/rtph.2002.1550 Document Type: Article |
Times cited : (31)
|
References (25)
|